When.com Web Search

  1. Ads

    related to: viatris epipen coupon program for seniors free pdf form

Search results

  1. Results From The WOW.Com Content Network
  2. Viatris - Wikipedia

    en.wikipedia.org/wiki/Viatris

    Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn , a legacy division of Pfizer , on November 16, 2020.

  3. Mylan - Wikipedia

    en.wikipedia.org/wiki/Mylan

    Questions had been raised by Congress and others about why EpiPen had been classified as a generic rather a proprietary product in the program since 1997; generic drugs have lower rebates (13%) than proprietary drugs (23%), and price hikes for generic drugs cannot be passed onto states, and a common form of pharmaceutical fraud involves ...

  4. 6 simple ways to save money on your prescriptions - AOL

    www.aol.com/finance/save-money-prescription...

    Coupons are free. You could save 80% or more on prescriptions ... Dig deeper: 80+ best discounts for mature adults, seniors and retirees. 4. Look into a patient assistance program (PAP ...

  5. 5 Ways Seniors Can Get Free Legal Assistance - AOL

    www.aol.com/5-ways-seniors-free-legal-171938257.html

    Navigating your way through difficult legal issues such as long-term care, estate planning, or social security benefits, as an aging American without adequate support is an overwhelming and...

  6. Epinephrine autoinjector - Wikipedia

    en.wikipedia.org/wiki/Epinephrine_autoinjector

    Questions had been raised by Congress and others about why EpiPen had been classified as a generic rather a proprietary product in the program since 1997; generic drugs have lower rebates (13%) than proprietary drugs (23%), and price hikes for generic drugs cannot be passed onto states, and a common form of pharmaceutical fraud involves ...

  7. Viatris to settle EpiPen antitrust litigation for $264 million

    www.aol.com/finance/viatris-settle-epipen...

    (Reuters) -Viatris Inc, the drugmaker formerly known as Mylan, said on Monday it had agreed to pay $264 million to resolve a class action lawsuit alleging it engaged in a scheme to delay generic ...